Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

BOLTREGN

Bolt Biotherapeutics, Inc.

BOLT · $6.83

37Weak

Regeneron Pharmaceuticals, Inc.

REGN · $782.04

73Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

BOLT

37/100

REGN

73/100

Quality

Is it a profitable, well-run business?

BOLT

2.0/10

REGN

6.2/10

Growth

Is the company growing?

BOLT

4.8/10

REGN

4.5/10

Valuation

Is the price reasonable? (higher = cheaper)

BOLT

3.3/10

REGN

6.9/10

Risk

How risky are the shares? (higher = lower risk)

BOLT

4.3/10

REGN

8.1/10

Momentum

Is the share price trending up?

BOLT

6.7/10

REGN

8.4/10

Financial strength

Is the balance sheet healthy?

BOLT

2.9/10

REGN

9.7/10

The balanced view

Model-generated

Bolt Biotherapeutics, Inc.

This company scores below average, with a positive price trend, although analysts are cautious.

Leads on: growth

Best feature: positive price trend (MACD histogram: 0.20)

Watch out: analysts are cautious (Target upside: -41.4%)

Regeneron Pharmaceuticals, Inc.

This company scores above average, with a healthy balance sheet and a positive price trend.

Leads on: quality, valuation, risk, momentum, financial strength

Best feature: healthy balance sheet (Altman Z-Score: 7.29)

Watch out: weakest area: growth potential (Revenue growth (FY): 1.0%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.